Send me real-time posts from this site at my email
Zacks

Why Earnings Season Could Be Great for Pear Therapeutics (PEAR)

Investors are always looking for stocks that are poised to beat at earnings season and Pear Therapeutics, Inc. PEAR may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

That is because Pear Therapeutics is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for PEAR in this report.

In fact, the Most Accurate Estimate for the current quarter is currently at a loss of 23 cents per share for PEAR, compared to a broader Zacks Consensus Estimate of a loss of 25 cents per share. This suggests that analysts have very recently bumped up their estimates for PEAR, giving the stock a Zacks Earnings ESP of +8.00% heading into earnings season.

Pear Therapeutics, Inc. Price and EPS Surprise

Pear Therapeutics, Inc. price-eps-surprise | Pear Therapeutics, Inc. Quote

Why is this Important?

A positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10-year backtest shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns (see more Top Earnings ESP stocks here).

Given that PEAR has a Zacks Rank #2 (Buy) and an ESP in positive territory, investors might want to consider this stock ahead of earnings. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Clearly, recent earnings estimate revisions suggest that good things are ahead for Pear Therapeutics, and that a beat might be in the cards for the upcoming report.


Profiting from the Metaverse, The 3rd Internet Boom (Free Report):

Get Zacks' special report revealing top profit plays for the internet's next evolution. Early investors still have time to get in near the "ground floor" of this $30 trillion opportunity. You'll discover 5 surprising stocks to help you cash in.

Download the report FREE today >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Pear Therapeutics, Inc. (PEAR): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue